Hormonal Treatment and Pelviscopic Myomectomy
Author Information
Author(s): L. Mettler, E. Alvarez-Rodas, K. Semm
Primary Institution: University of Kiel
Hypothesis
Can gonadotropin releasing hormone analogues effectively reduce the size of uterine myomas before myomectomy?
Conclusion
The study found that preoperative treatment with GnRH-a resulted in a significant reduction in myoma size, allowing for safer and less invasive surgical procedures.
Supporting Evidence
- Pelviscopy was used in 57% of all abdominal operations for myomas.
- 88% of patients showed a 10% to 50% reduction in myoma size after treatment.
- No serious complications occurred during the procedures.
- Preoperative treatment with GnRH-a was shown to be effective in reducing myoma size.
Takeaway
Doctors can use special hormones to shrink fibroids in women's uterus before surgery, making the surgery easier and safer.
Methodology
The study involved 851 patients treated with various surgical techniques for myomas, with 116 patients receiving GnRH-a treatment prior to surgery.
Limitations
The study may not account for long-term outcomes or complications beyond the immediate postoperative period.
Participant Demographics
Average age of participants was 43.2 years, with 60% being nulliparous.
Want to read the original?
Access the complete publication on the publisher's website